Skip to content
healthcare.dev

Valganciclovir hydrochloride for Oral

NDC 0591-2579, Valganciclovir hydrochloride, powder, for solution, from Actavis Pharma, Inc..

Product NDC
0591-2579
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205220
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2579 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VALGANCICLOVIR HYDROCHLORIDE50 mg/mL

Pharmacologic classes

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
0591-2579-2000591257920100 mL in 1 BOTTLE, GLASS (0591-2579-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/92281301-5fb5-4eea-8766-4863e241c234
  • NADAC price for package 00591257920

    GET /v1/drugs/nadac/00591257920

Use it

Look up 0591-2579 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2579 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2579. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.